Ingestion of dipyridamole reduces inhibitory effect of prostacyclin on human platelets.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000328:Adult; D001095:Arachidonic Acids / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology*; D011464:Epoprostenol / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D011448:Prostaglandin Antagonists; D011457:Prostaglandins D / Q000037:antagonists & inhibitors; D011458:Prostaglandins E / Q000037:antagonists & inhibitors
D001095:Arachidonic Acids; D011448:Prostaglandin Antagonists; D011457:Prostaglandins D; D011458:Prostaglandins E; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D003094:Collagen; D011464:Epoprostenol